PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
17-Sep-2024 CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness AccessWire
17-Sep-2024 Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA AccessWire
17-Sep-2024 Phi Huynh, DPM, Joins Modern Foot & Ankle, Expanding Services in Houston, Texas AccessWire
17-Sep-2024 Angle PLC Announces Notice of Interim Results and Webcast AccessWire
17-Sep-2024 Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules AccessWire
17-Sep-2024 Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules AccessWire
16-Sep-2024 Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024 AccessWire
16-Sep-2024 Nutriband Inc. Authorizes $1M Share Buyback Program AccessWire
16-Sep-2024 Hypha Labs, Inc. Uplists to the OTCQB AccessWire
16-Sep-2024 Aspen Dental: Caring for Dental Implants: Maintenance Tips and Common Issues AccessWire
16-Sep-2024 DistillerSR Adopts NIST AI Risk Management Framework (RMF) to Ensure the Continued Development of Trustworthy AI Solutions AccessWire
16-Sep-2024 Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference AccessWire
16-Sep-2024 Innovista Health Appoints Managed Care Leader Jigar Desai as New CEO AccessWire
16-Sep-2024 ONI Expands Horizons: Entering the Lipid Nanoparticle Research Market AccessWire
16-Sep-2024 Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar AccessWire
16-Sep-2024 Med Holdings Group Inc. Formerly Yuka Group (YUKA) Announces Expansion Plans and New Business Initiatives AccessWire
16-Sep-2024 Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study AccessWire
16-Sep-2024 Tharimmune Acquires Global License and Partners With Intract Pharma to Develop an Oral Formulation of Infliximab AccessWire
16-Sep-2024 Health Systems Brace for Significant 2025 Cost Surge, Shift to GPOs and Outsourcing for Supply Chain Solutions, Black Book Survey Finds AccessWire
13-Sep-2024 Moolec Received NASDAQ Bid Price Letter AccessWire